He holds a postgraduate degree in Pharmaceutical Sciences from Rajiv Gandhi University of Health Sciences, Karnataka. With over 22 years of extensive experience in the pharmaceutical industry, he has been instrumental in developing a wide array of drug products. These include solid oral dosage forms, liquid orals, topical applications and both liquid and lyophilized injectables. His expertise spans the creation of generic equivalents, complex generics and differentiated products under the 505(b)2 category in the US, as well as hybrid applications in the EU.
His profound knowledge encompasses the entire spectrum of pre-clinical and clinical development for differentiated products. He has successfully guided numerous projects through stringent regulatory audits and inspections, many of which concluded without any observations, highlighting his meticulous attention to regulatory compliance and quality standards. His comprehensive understanding of the pharmaceutical value chain includes deep insights into regulatory, quality and business aspects, making him a versatile and valuable asset in the industry.
In addition to his hands-on experience, Krishna offers consulting services in pharmaceutical research and development, catering to various geographies and organizations. His strategic guidance and expertise have been sought after by numerous companies looking to navigate the complex landscape of pharmaceutical development and regulation.
Before founding WohlStand Pharma, He held significant roles at prominent pharmaceutical companies such as Shilpa Medicare, Zydus Healthcare, Ranbaxy and Strides Arcolab. In these positions, he made substantial contributions to advancing pharmaceutical sciences, driving innovation and ensuring the highest standards of product quality and regulatory compliance.